Leotta, D.; Duminuco, A.; Parisi, M.S.; Caruso, L.; Markovic, U.; Longo, E.; Di Raimondo, F.; Palumbo, G.A.; Chiarenza, A.
Debulking Therapy with Obinutuzumab Is Helpful and Safe in Chronic Lymphocytic Leukemia with Extreme Hyperleukocytosis: A Case Report. Onco 2025, 5, 10.
https://doi.org/10.3390/onco5010010
AMA Style
Leotta D, Duminuco A, Parisi MS, Caruso L, Markovic U, Longo E, Di Raimondo F, Palumbo GA, Chiarenza A.
Debulking Therapy with Obinutuzumab Is Helpful and Safe in Chronic Lymphocytic Leukemia with Extreme Hyperleukocytosis: A Case Report. Onco. 2025; 5(1):10.
https://doi.org/10.3390/onco5010010
Chicago/Turabian Style
Leotta, Dario, Andrea Duminuco, Marina Silvia Parisi, Laura Caruso, Uros Markovic, Ermelinda Longo, Francesco Di Raimondo, Giuseppe Alberto Palumbo, and Annalisa Chiarenza.
2025. "Debulking Therapy with Obinutuzumab Is Helpful and Safe in Chronic Lymphocytic Leukemia with Extreme Hyperleukocytosis: A Case Report" Onco 5, no. 1: 10.
https://doi.org/10.3390/onco5010010
APA Style
Leotta, D., Duminuco, A., Parisi, M. S., Caruso, L., Markovic, U., Longo, E., Di Raimondo, F., Palumbo, G. A., & Chiarenza, A.
(2025). Debulking Therapy with Obinutuzumab Is Helpful and Safe in Chronic Lymphocytic Leukemia with Extreme Hyperleukocytosis: A Case Report. Onco, 5(1), 10.
https://doi.org/10.3390/onco5010010